Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

14
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

25
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

175
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rhabdomyolysis: a narrative review.

Arquivos de neuro-psiquiatria·2026
Same author

Andersen-Tawil syndrome: visual clues to the diagnosis.

Arquivos de neuro-psiquiatria·2026
Same author

Clinical Characterization of Patients With 5q Spinal Muscular Atrophy Types 2 and 3 in Brazil: A Cross-Sectional Observational Study.

Clinical genetics·2026
Same author

Unmet Needs in the Care of Patients with Duchenne Muscular Dystrophy in Brazil.

Arquivos de neuro-psiquiatria·2026
Same author

Brazilian version of the ACTIVLIM: translation, cultural adaptation, and validation for neuromuscular disorders.

Arquivos de neuro-psiquiatria·2026
Same author

Neurological symptoms and physical exam findings 6-11 months post-COVID-19: a cohort study.

Scientific reports·2026

Related Experiment Video

Updated: Sep 1, 2025

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.6K

Inflammatory myopathies: an update for neurologists.

André Macedo Serafim Silva1, Eliene Dutra Campos1, Edmar Zanoteli1

  • 1Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.

Arquivos De Neuro-Psiquiatria
|August 17, 2022
PubMed
Summary

Idiopathic inflammatory myopathies (IIM) are treatable conditions characterized by muscle weakness. Recent advances in understanding autoantibodies have refined IIM classification and diagnosis, improving patient care.

More Related Videos

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

542
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K

Related Experiment Videos

Last Updated: Sep 1, 2025

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.6K
Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

542
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Idiopathic inflammatory myopathies (IIM) are a diverse group of treatable muscle disorders.
  • Patients typically present with proximal muscle weakness, and may have extramuscular symptoms affecting lungs, skin, or joints.
  • Traditional diagnosis relied on creatine kinase levels, EMG, and muscle biopsy.

Purpose of the Study:

  • To review updated classification and diagnostic approaches for IIM.
  • To discuss the increasing role of autoantibodies in IIM diagnosis.
  • To outline treatment strategies for IIM patients.

Main Methods:

  • Review of current literature on IIM classification and diagnosis.
  • Analysis of the evolving role of autoantibodies in serological testing.
  • Synthesis of clinical guidelines for IIM management.

Main Results:

  • IIM classification has expanded beyond polymyositis, dermatomyositis, and inclusion body myopathy.
  • Newer classifications include immune-mediated necrotizing myopathy, overlap myositis, and antisynthetase syndrome.
  • Autoantibodies are now identified in over half of IIM patients, aiding in seropositive IIM diagnosis.

Conclusions:

  • The understanding of IIM has significantly advanced, leading to revised classifications.
  • Serological markers (autoantibodies) are crucial for accurate IIM diagnosis and subtyping.
  • Personalized treatment plans based on new classifications improve patient outcomes.